Publications

Journal Article Epublish
Open access — free full text available
Open access
Electronic publication date
August 12, 2026

View on Pubmed.gov 42582106 | View on doi.org 10.3389/fstro.2... | View the free full text Full text

Anemia impacts short-term and long-term mortality risk after acute ischemic stroke.

Search for publications in this journal Front Stroke

Abstract

BACKGROUND

The relationship between hemoglobin concentration and all-cause mortality in acute ischemic stroke (AIS) patients remains unclear due to conflicting findings. This study aims to evaluate the impact of hemoglobin concentration on the risk of both short-term and long-term all-cause mortality in AIS patients from a nationwide stroke registry.

METHOD

We utilized data from the Singapore Stroke Registry (SSR), including patients >18years old at first AIS onset, and received treatment at a local hospital between 2005 and 2020. Patients were stratified according to sex-specific hemoglobin concentration cut-offs on anemia severity and polycythemia from the World Health Organization. Multivariate logistic regression and Cox proportional hazards modeling were performed, adjusting for demographics and cardiovascular risk factors.

RESULTS

A total of 56,884 ischemic stroke patients were included, of which 66.8% had no anemia, 15.7% had mild anemia, 12.2% had severe anemia, and 5.3% had polycythemia. The cohort was predominantly male (57%), with a median age of 68 years. The median follow-up duration was 10-years (IQR 7-13). Compared to patients with normal-range hemoglobin, both mild and severe anemia was associated with elevated short-term and long-term risks of all-cause mortality. Severe anemia was associated with the highest risk of all-cause mortality, with hazard ratios of 1.99 (95%CI:1.92-2.06) at 30-days, 1.73 (95%CI:1.66-1.81) at 1-year, and 1.52 (95%CI:1.41-1.64) at 5-years. However, the excess risk associated with severe anemia appeared to attenuate at 10-years, whilst the elevated risk persisted among patients with mild anemia.

CONCLUSION

In this nationwide stroke registry, anemia is prevalent among AIS patients and is significantly associated with both short-term and long-term mortality.

References

Adhami F., Liao G., Morozov Y. M., Schloemer A., Schmithorst V. J., Lorenz J. N., et al. (2006). Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. Am. J. Pathol. 169, 566–583. doi: 10.2353/ajpath.2006.051066

Allport L. E., Parsons M. W., Butcher K. S., MacGregor L., Desmond P. M., Tress B. M., et al. (2005). Elevated hematocrit is associated with reduced reperfusion and tissue survival in acute stroke. Neurology 8:9. doi: 10.1212/01.wnl.0000183057.96792.a8

Barlas R. S., Honney K., Loke Y. K., McCall S. J., Bettencourt-Silva J. H., Clark A. B., et al. (2016). Impact of hemoglobin levels and anemia on mortality in acute stroke: analysis of UK regional registry data, systematic review, and meta-analysis. J. Am. Heart Assoc. 5:3019. doi: 10.1161/JAHA.115.003019

Bateman G. A., Bateman A. R. (2024). Anemia in idiopathic intracranial hypertension increases cerebral blood flow and the intracranial pressure. J. Neuroophthalmol 44, 282–283. doi: 10.1097/WNO.0000000000001977

Conflict of interest statement

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors BT, LY declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

MeSH

Specialties

Copyright

Copyright © 2026 Low, Wong, Yau, Tan, Teo, Teo, Senff, Tack, Ho, Chan, Yeo, Yeo, Sia and Tan.